Results 121 to 130 of about 9,597 (210)

The interplay between WASH practices and vaccination with oral cholera vaccines in protecting against cholera in urban Bangladesh: Reanalysis of a cluster-randomized trial. [PDF]

The current global initiative to end Cholera by 2030 emphasizes the use of oral cholera vaccine (OCV) combined with feasible household Water-Sanitation-Hygiene (WASH) interventions. However, little is known about how improved WASH practices and behaviors
Liu, X, Aziz, AB, Tadesse, BT, Im, J, Hoque, M, Kim, DR, Ahmed, T, Kang, SS, Khan, AI, Clemens, JD, Islam, MT, Qadri, F, Pak, G, Ahmmed, F, McMillan, NAJ, Zaman, K, Marks, F, Kim, JH, Chowdhury, F, Park, J, Khanam, F   +20 more
core   +1 more source

Vaccination against cholera and ETEC diarrhea and interventions to improve vaccine immune responses. [PDF]

, 2009
Vaccination against cholera and ETEC diarrhea and interventions to improve vaccine immune responses Abstract Vibrio cholerae O1 and enterotoxigenic Escherichia coli (ETEC) together account for the majority of bacterial causes of acute dehydrating ...
Ahmed, Tanvir
core  

Cholera epidemiology analysis through the experience of the 1973 Naples epidemic

Open Medicine
The World Health Organization (WHO) appeal of January 15, 2024, stated “The current number, size and concurrence of multiple outbreaks, the spread to areas free of cholera for decades and alarmingly high mortality rates present a major threat to global ...
Bifulco Maurizio, Di Zazzo Erika, Pagano Cristina, Martini Mariano, Orsini Davide   +4 more
doaj   +1 more source

The management of cholera in populations affected by conflict in Africa and the Middle-East: a scoping review

Conflict and Health
Background Cholera is a life-threatening disease caused by ingesting food or water contaminated with V. cholerae. Armed conflicts disrupt healthcare infrastructure, limit access to clean water, and exacerbate population displacement, leading to increased
Rayan Mohamed, Yosra AdamSabi, Saria Hassan, Anfal Mahmoud, Doaa Mohammadat, Eslam S. Abdalla, Gawaher Mutawali, Ladin Ali, Lana Shabat, Lina Mohamedahmed, Maha Qassim, Monzer Seedahmed, Mowafag H. Salih, Alrumaisa Alhassan, Mohammed Hamed Ibrahium Badi   +14 more
doaj   +1 more source

Oral cholera vaccine coverage evaluation survey: Forcibly Displaced Myanmar Nationals and host community in Cox's Bazar, Bangladesh. [PDF]

Front Public Health, 2023
Qayum MO, Billah MM, Sarker MFR, Alamgir ASM, Nurunnahar M, Khan MH, Salim Uzzaman M, Henderson A, Shirin T, Flora MS.   +9 more
europepmc   +1 more source

Cost of oral cholera vaccine delivery in a mass immunization program for children in urban Bangladesh. [PDF]

Vaccine X, 2022
Sarker AR, Khan AI, Islam MT, Chowdhury F, Khanam F, Kang S, Ahmmed F, Im J, Kim DR, Tadesse BT, Ahmed T, Aziz AB, Hoque M, Park J, Liu X, Pak G, Zaman K, Marks F, Kim JH, Clemens JD, Qadri F.   +20 more
europepmc   +1 more source

Assessment of the influence of ABO blood groups on oral cholera vaccine immunogenicity in a cholera endemic area in Zambia. [PDF]

BMC Public Health, 2023
Chisenga CC, Bosomprah S, Chilyabanyama ON, Alabi P, Simuyandi M, Mwaba J, Ng'ombe H, Laban NM, Luchen CC, Chilengi R.   +9 more
europepmc   +1 more source

Challenges for Programmatic Implementation of Oral Cholera Vaccine in India. [PDF]

J Infect Dis, 2021
Chakraborty D, Kanungo S, Kumar Nandy R, Kumar Deb A, Kumar Mukhopadhyay A, Dutta S.   +5 more
europepmc   +1 more source

An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon. [PDF]

Am J Trop Med Hyg, 2022
Ateudjieu J, Sack DA, Nafack SS, Xiao S, Tchio-Nighie KH, Tchokomeni H, Bita'a LB, Nyibio PN, Guenou E, Mondung KM, Dieumo FFK, Ngome RM, Murt KN, Ram M, Ali M, Debes AK.   +15 more
europepmc   +1 more source

Cholera Vaccine Inactivated Oral

Drugs in R & D, 1999
openaire   +2 more sources